Position in EYPT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,036,965
+$6,866,517 QoQ
Shares Held
841,746
+109.8% QoQ
Ownership
0.976%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 188 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 88%
Shared 8%
None 4%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. EYPT ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in EYPT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,036,965 | 841,746 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,170,448 | 401,121 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,345,689 | 402,063 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,262,198 | 229,087 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $658,341 | 69,962 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $123,125 | 22,717 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $169,241 | 22,717 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $197,991 | 24,780 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $247,488 | 28,447 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $612,038 | 29,610 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $684,286 | 29,610 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $400,465 | 50,121 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $520,816 | 59,864 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $175,999 | 59,864 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $218,984 | 62,567 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $730,978 | 92,412 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $799,583 | 101,599 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,458,510 | 120,042 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $649,319 | 53,049 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $210,765 | 20,227 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $188,088 | 20,922 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||